Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T15:55:56.070Z.
Consensus retrieved: 2026-10-06T10:22:53.954Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T15:55:56.070Z.
Quote observation: 2026-10-06T15:55:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ea268c636d02c1563f9a0cc17fa45ef3048b6802d4031696aa30e1bc9d7aaf2a
Forward PE Ratio (N/A) = Dated Quote Price ($0.97) / Consensus Forward EPS ($-1.00)
FORWARD PE RATIO
N/A
Connect Biopharma Holdings Limited
Market Cap
$61.25M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Connect Biopharma Holdings Limited (CNTB) | $61.25M | N/A |
| Adicet Bio, Inc. (ACET)vs › | $60.86M | N/A |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.18M | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $62.54M | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $59.37M | N/A |
| Alps Group Inc (ALPS)vs › | $63.23M | N/A |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.75M | N/A |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $58.66M | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.55M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $0.97, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-1.00 | $-1.10 – $-0.84 | 5 | n/m |
| 2027-12-31 | $-0.71 | $-0.95 – $-0.47 | 6 | n/m |
| 2028-12-31 | $-0.81 | $-1.74 – $-0.36 | 5 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
